Phase III Multicentric Open Study to Evaluate Immunological Memory Induced by 3-dose Primary Vaccination Followed by Booster Dose of GSK Biologicals' 11-valent Conjugate Pneumococcal Vaccine Compared to Unprimed Subjects by Giving 1 Dose of Aventis Pasteur's Pneumo 23
Latest Information Update: 05 Sep 2023
At a glance
- Drugs Pneumococcal 11-valent vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Hepatitis A; Hepatitis B; Pneumococcal infections
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 05 Jun 2017 New trial record